Company intelligence / Profile preview

Agility Life Sciences

Stapleford, England, United Kingdomagilitylifesciences.com ↗

Ownership: Private
Development stage: Other

Overview

Agility Life Sciences is an award-winning formulation development CDMO specializing in transforming challenging pharmaceutical molecules into effective formulations. Their expertise accelerates preclinical milestones and supports progression to clinical and commercial stages. They do not develop their own therapeutics but provide services that enable clients’ drug candidates to advance more efficiently through the pipeline.

Modalities: Small moleculePeptidesLipid nanoparticle delivery therapyLiposomal formulation
Industry: Contract Manufacturing Organization

Partnerships

Solitek (strategic partnership for solid state development services)

Beyond the preview

Go deeper on Agility Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agility Life Sciences.

Explore the full profile